The landscape of dementia analysis has developed dramatically with the arrival of complex biomarkers, including amyloid PET scans, tau imaging, and blood-primarily based exams that could detect Alzheimer's pathology decades before signs emerge. Even though these technological advancements characterize remarkable development in understanding neurode